PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview

被引：6
|
作者：
Caracciolo, Matteo [1 ]
Castello, Angelo [2 ]
Lopci, Egesta [3 ,4 ]
机构：
[1] Univ Hosp Ferrara, Oncol Med & Specialists Dept, Nucl Med Unit, Ferrara, Italy
[2] Fdn IRCCS CaGranda, Osped Maggiore Policlin, Nucl Med Unit, Milan, Italy
[3] IRCCS, Human Res Hosp, Nucl Med Unit, Milan, Italy
[4] IRCCS, Human Res Hosp, Nucl Med Unit, Via Manzoni 56, I-20089 Milan, Italy
来源：
SEMINARS IN NUCLEAR MEDICINE | 2024年 / 54卷 / 01期
关键词：
GA-68-PSMA PET/CT; DIAGNOSTIC-ACCURACY; BIOPSY; VALIDATION; MRI; PSA;
D O I：
10.1053/j.semnuclmed.2023.10.002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
In the last years, PSMA-PET imaging and multiparametric MRI (mpMRI) have improved the clinical management of prostate cancer (PCa) patients. Currently, mpMRI is recommended by the EAU (European Association of Urology) guidelines for the primary diagnosis of PCa, whereas PSMA-PET is reserved for disease staging, particularly in high risk localized or locally advanced disease, as well as for biochemical recurrence after surgery. Nevertheless, several studies have explored the added value of PSMA-PET in other clinical scenar-ios, including primary diagnosis and especially for the detection of clinically significant PCa (csPCa). In the present contribution, we will provide an overview and an update on the cur-rent literature on imaging detection of csPCa, with a particular focus on mpMRI, PSMA-PET and their comparison. Semin Nucl Med 54:30-38 (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：30 / 38
页数：9
相关论文
共 50 条
  • [21] 68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results
    Liu, Chen
    Liu, Teli
    Zhang, Zhongyi
    Zhang, Ning
    Dui, Peng
    Yang, Yong
    Liu, Yiqiang
    Yus, Wei
    Li, Nan
    Gorin, Michael A.
    Rowe, Steven P.
    Zhu, Hua
    Yang, Kun
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (09) : 1314 - 1319
  • [22] Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
    Chen, Haojie
    Qian, Yuhang
    Wu, Yanyuan
    Shi, Bowen
    Zhou, Jiatong
    Qu, Fajun
    Gu, Zhengqin
    Ding, Jie
    Yu, Yongjiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance
    Akcay, Kaan
    Kibar, Ali
    Sahin, Onur Erdem
    Demirbilek, Muhammet
    Beydagi, Gamze
    Asa, Sertac
    Aghazada, Fuad
    Toklu, Turkay
    Selcuk, Nalan Alan
    Onal, Bulent
    Kabasakal, Levent
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (05) : 1467 - 1475
  • [24] Molecular imaging for prostate cancer: Performance analysis of 68Ga-PSMA PET/CT versus choline PET/CT
    Michaud, L.
    Touijer, K. A.
    ACTAS UROLOGICAS ESPANOLAS, 2017, 41 (05): : 292 - 299
  • [25] Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis
    Treglia, Giorgio
    Mestre, Ricardo Pereira
    Ferrari, Matteo
    Bosetti, Davide G.
    Pascale, Mariarosa
    Oikonomou, Eleni
    De Dosso, Sara
    Jermini, Fernando
    Prior, John O.
    Roggero, Enrico
    Giovanella, Luca
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 9 (02): : 127 - 139
  • [26] The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI
    Song, Jihui
    Zhao, Chenglin
    Zhang, Fei
    Yuan, Yingdi
    Wang, Lee M.
    Sah, Vivek
    Zhang, Jun
    Weng, Wencai
    Yang, Zhenghan
    Wang, Zhenchang
    Wang, Liang
    ABDOMINAL RADIOLOGY, 2023, 48 (02) : 704 - 712
  • [27] Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer
    Robinson, Hunter S.
    Lee, Sangmyung S.
    Barocas, Daniel A.
    Tosoian, Jeffrey J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, : 45 - 55
  • [28] PSMA PET/CT and radiotherapy in prostate cancer: a winning team
    Caroli, P.
    Romeo, A.
    Parisi, E.
    Sarnelli, A.
    Di Iorio, V
    Paganelli, G.
    Matteucci, F.
    CLINICAL AND TRANSLATIONAL IMAGING, 2022, 10 (02) : 163 - 172
  • [29] 68Ga-PSMA PET/CT in prostate cancer
    Garcia Garzon, J. R.
    de Arcocha Torres, M.
    Delgado-Bolton, R.
    Ceci, F.
    Alvarez Ruiz, S.
    Orcajo Rincon, J.
    Caresia Aroztegui, A. P.
    Garcia Velloso, M. J.
    Garcia Vicente, A. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
  • [30] Ductal prostate cancer staging: Role of PSMA PET/CT
    Pietro, Pepe
    Ludovica, Pepe
    Mara, Curduman
    Michele, Pennisi
    Filippo, Fraggetta
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2024, 96 (01)
12345